English

SELECTA BIOSCIENCES, INC.

EDGAR

RNAC Quarterly report (10-Q) · filed 2026-08-06

Annual consolidated revenue for 2025: about USD 2.797M, using the latest reported figures. The previous period, 2024, was about USD 38.91M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-21.1 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -43217000 USD Source
Operating Cash Flow: -22135000 USD Source

Free cash flow

-21.4 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -43217000 USD Source
Operating Cash Flow: -22135000 USD Source
Capital Expenditure: 299000 USD Source
Capital Expenditure: 27000 USD Source

Cash and cash equivalents: 148 million USD 2026-06-30 Source
Exact value

147606000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 30 million shares 2026-06-30 Source
Exact value

30037962 shares

Reported share-count change

15.53% · 4.04 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

26000065 shares · 2025-06-30· Source
30037962 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.48 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 452000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 2797000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 1850000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 78000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 0 USD · 2026-04-01 – 2026-06-30 Source

Net income

-152 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -35902000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -130302000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -37726000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -39182000 USD · 2026-01-01 – 2026-03-31 Source
Net income: 15769000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-76.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -56229000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -40629000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -73941000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -56229000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -22135000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -43217000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -22135000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

2.08 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 4962000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 3670000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 5454000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 4962000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 27000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 299000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 27000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-78.6 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -56229000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -40629000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -73941000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -56229000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -22135000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -43217000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -22135000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 4962000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 3670000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 5454000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 4962000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 27000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 299000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 27000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-06.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-92.8%

Prior period

USD 38.91 million

2024-01-01 – 2024-12-31
Current period

USD 2.8 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

2797000 − 38913000 = -36116000 USD

38913000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
2797000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SELECTA BIOSCIENCES, INC. · 2025-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Year-over-year change in Revenue: -36116000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2797000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1118645 Filing: 000145368726000064 Input fundies:Revenue: 38913000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1119257 Filing: 000145368726000064
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 52.88 million

Prior period

−USD 77.42 million

2024-01-01 – 2024-12-31
Current period

−USD 130.3 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-130302000 − -77424000 = -52878000 USD

-77424000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-130302000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SELECTA BIOSCIENCES, INC. · 2025-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Year-over-year change in Net income: -52878000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -130302000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1346755 Filing: 000145368726000064 Input fundies:NetIncome: -77424000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1347529 Filing: 000145368726000064
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 50.27 million

Prior period

−USD 23.67 million

2024-01-01 – 2024-12-31
Current period

−USD 73.94 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-73941000 − -23674000 = -50267000 USD

-23674000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-73941000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SELECTA BIOSCIENCES, INC. · 2025-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Year-over-year change in Operating cash flow: -50267000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -73941000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1377143 Filing: 000145368726000064 Input fundies:OperatingCashFlow: -23674000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1377801 Filing: 000145368726000064
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-40%

Prior period

USD 9.09 million

2024-01-01 – 2024-12-31
Current period

USD 5.45 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

5454000 − 9093000 = -3639000 USD

9093000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
5454000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SELECTA BIOSCIENCES, INC. · 2025-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Year-over-year change in Capital expenditure: -3639000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 5454000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1381633 Filing: 000145368726000064 Input fundies:CapitalExpenditure: 9093000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1382223 Filing: 000145368726000064
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 2.8 million 100% of revenue
Operating costs Derived USD 146.2 million 5,227% of revenue
Operating income −USD 143.41 million −5,127% of revenue
Tax, interest and other Derived −USD 13.1 million −468% of revenue
Net income −USD 130.3 million −4,659% of revenue

Cash

Operating cash flow −USD 73.94 million −2,644% of revenue
Capital expenditure USD 5.45 million 195% of revenue
Free cash flow Derived −USD 79.4 million −2,839% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 529% of revenue.
2017 Operating loss: operating costs were 30,914% of revenue.
2018 Operating loss: operating costs were 7,301% of revenue.
2019 Operating loss: operating costs were 886% of revenue.
2020 Operating loss: operating costs were 442% of revenue.
2021 Operating loss: operating costs were 105% of revenue.
2022 Net income was higher than operating income, so the split is not drawn.
2023 Operating loss: operating costs were 432% of revenue.
2024 Operating loss: operating costs were 213% of revenue.
2025 Operating loss: operating costs were 5,227% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	8083000	42753000 Derived	-34670000	1540000 Derived	-36210000	-20343000 Derived	Source 2016-01-01 – 2016-12-31: 8083000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -34670000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -36210000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -19757000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 586000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	207000	63991000 Derived	-63784000	1537000 Derived	-65321000	-52759000 Derived	Source 2017-01-01 – 2017-12-31: 207000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -63784000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -65321000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -52026000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 733000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	903000	65925000 Derived	-65022000	314000 Derived	-65336000	-60045000 Derived	Source 2018-01-01 – 2018-12-31: 903000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -65022000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -65336000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -59161000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 884000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	6677000	59132000 Derived	-52455000	2895000 Derived	-55350000	-51482000 Derived	Source 2019-01-01 – 2019-12-31: 6677000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -52455000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -55350000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -51435000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 47000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	16597000	73418000 Derived	-56821000	12055000 Derived	-68876000	34066000 Derived	Source 2020-01-01 – 2020-12-31: 16597000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -56821000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -68876000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 34881000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 815000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	85077000	89674000 Derived	-4597000	21090000 Derived	-25687000	-61467000 Derived	Source 2021-01-01 – 2021-12-31: 85077000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -4597000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -25687000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -60382000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 1085000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	110777000	96239000 Derived	14538000	-20841000 Derived	35379000	-32832000 Derived	Source 2022-01-01 – 2022-12-31: 110777000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 14538000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 35379000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -31631000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 1201000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	26004000	112420000 Derived	-86416000	133294000 Derived	-219710000	-51367000 Derived	Source 2023-01-01 – 2023-12-31: 26004000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -86416000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -219710000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -51161000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 206000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	38913000	82810000 Derived	-43897000	33527000 Derived	-77424000	-32767000 Derived	Source 2024-01-01 – 2024-12-31: 38913000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -43897000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -77424000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -23674000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 9093000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	2797000	146202000 Derived	-143405000	-13103000 Derived	-130302000	-79395000 Derived	Source 2025-01-01 – 2025-12-31: 2797000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -143405000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -130302000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -73941000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 5454000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.8M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	8083000	Revenue: 8083000 Open source
20172017-12-31	Revenue	207000	Revenue: 207000 Open source
20182018-12-31	Revenue	903000	Revenue: 903000 Open source
20192019-12-31	Revenue	6677000	Revenue: 6677000 Open source
20202020-12-31	Revenue	16597000	Revenue: 16597000 Open source
20212021-12-31	Revenue	85077000	Revenue: 85077000 Open source
20222022-12-31	Revenue	110777000	Revenue: 110777000 Open source
20232023-12-31	Revenue	26004000	Revenue: 26004000 Open source
20242024-12-31	Revenue	38913000	Revenue: 38913000 Open source
20252025-12-31	Revenue	2797000	Revenue: 2797000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-92.8% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	34.5%	Revenue: 8083000 Open source Revenue: 6011000 Open source
20172017-12-31	Year over year	-97.4%	Revenue: 207000 Open source Revenue: 8083000 Open source
20182018-12-31	Year over year	336.2%	Revenue: 903000 Open source Revenue: 207000 Open source
20192019-12-31	Year over year	639.4%	Revenue: 6677000 Open source Revenue: 903000 Open source
20202020-12-31	Year over year	148.6%	Revenue: 16597000 Open source Revenue: 6677000 Open source
20212021-12-31	Year over year	412.6%	Revenue: 85077000 Open source Revenue: 16597000 Open source
20222022-12-31	Year over year	30.2%	Revenue: 110777000 Open source Revenue: 85077000 Open source
20232023-12-31	Year over year	-76.5%	Revenue: 26004000 Open source Revenue: 110777000 Open source
20242024-12-31	Year over year	49.6%	Revenue: 38913000 Open source Revenue: 26004000 Open source
20252025-12-31	Year over year	-92.8%	Revenue: 2797000 Open source Revenue: 38913000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -5,127.1% 2025

Net margin -4,658.6% 2025

Free cash flow margin -2,838.6% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-428.9%	Operating Income: -34670000 Open source Revenue: 8083000 Open source
20172017-12-31	Operating margin	-30,813.5%	Operating Income: -63784000 Open source Revenue: 207000 Open source
20182018-12-31	Operating margin	-7,200.7%	Operating Income: -65022000 Open source Revenue: 903000 Open source
20192019-12-31	Operating margin	-785.6%	Operating Income: -52455000 Open source Revenue: 6677000 Open source
20202020-12-31	Operating margin	-342.4%	Operating Income: -56821000 Open source Revenue: 16597000 Open source
20212021-12-31	Operating margin	-5.4%	Operating Income: -4597000 Open source Revenue: 85077000 Open source
20222022-12-31	Operating margin	13.1%	Operating Income: 14538000 Open source Revenue: 110777000 Open source
20232023-12-31	Operating margin	-332.3%	Operating Income: -86416000 Open source Revenue: 26004000 Open source
20242024-12-31	Operating margin	-112.8%	Operating Income: -43897000 Open source Revenue: 38913000 Open source
20252025-12-31	Operating margin	-5,127.1%	Operating Income: -143405000 Open source Revenue: 2797000 Open source
20162016-12-31	Net margin	-448%	Net Income: -36210000 Open source Revenue: 8083000 Open source
20172017-12-31	Net margin	-31,556%	Net Income: -65321000 Open source Revenue: 207000 Open source
20182018-12-31	Net margin	-7,235.4%	Net Income: -65336000 Open source Revenue: 903000 Open source
20192019-12-31	Net margin	-829%	Net Income: -55350000 Open source Revenue: 6677000 Open source
20202020-12-31	Net margin	-415%	Net Income: -68876000 Open source Revenue: 16597000 Open source
20212021-12-31	Net margin	-30.2%	Net Income: -25687000 Open source Revenue: 85077000 Open source
20222022-12-31	Net margin	31.9%	Net Income: 35379000 Open source Revenue: 110777000 Open source
20232023-12-31	Net margin	-844.9%	Net Income: -219710000 Open source Revenue: 26004000 Open source
20242024-12-31	Net margin	-199%	Net Income: -77424000 Open source Revenue: 38913000 Open source
20252025-12-31	Net margin	-4,658.6%	Net Income: -130302000 Open source Revenue: 2797000 Open source
20162016-12-31	Free cash flow margin	-251.7%	Revenue: 8083000 Open source Operating Cash Flow: -19757000 Open source Capital Expenditure: 586000 Open source
20172017-12-31	Free cash flow margin	-25,487.4%	Revenue: 207000 Open source Operating Cash Flow: -52026000 Open source Capital Expenditure: 733000 Open source
20182018-12-31	Free cash flow margin	-6,649.5%	Revenue: 903000 Open source Operating Cash Flow: -59161000 Open source Capital Expenditure: 884000 Open source
20192019-12-31	Free cash flow margin	-771%	Revenue: 6677000 Open source Operating Cash Flow: -51435000 Open source Capital Expenditure: 47000 Open source
20202020-12-31	Free cash flow margin	205.3%	Revenue: 16597000 Open source Operating Cash Flow: 34881000 Open source Capital Expenditure: 815000 Open source
20212021-12-31	Free cash flow margin	-72.2%	Revenue: 85077000 Open source Operating Cash Flow: -60382000 Open source Capital Expenditure: 1085000 Open source
20222022-12-31	Free cash flow margin	-29.6%	Revenue: 110777000 Open source Operating Cash Flow: -31631000 Open source Capital Expenditure: 1201000 Open source
20232023-12-31	Free cash flow margin	-197.5%	Revenue: 26004000 Open source Operating Cash Flow: -51161000 Open source Capital Expenditure: 206000 Open source
20242024-12-31	Free cash flow margin	-84.2%	Revenue: 38913000 Open source Operating Cash Flow: -23674000 Open source Capital Expenditure: 9093000 Open source
20252025-12-31	Free cash flow margin	-2,838.6%	Revenue: 2797000 Open source Operating Cash Flow: -73941000 Open source Capital Expenditure: 5454000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -73.9M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-19757000	Operating Cash Flow: -19757000 Open source
20172017-12-31	Operating cash flow	-52026000	Operating Cash Flow: -52026000 Open source
20182018-12-31	Operating cash flow	-59161000	Operating Cash Flow: -59161000 Open source
20192019-12-31	Operating cash flow	-51435000	Operating Cash Flow: -51435000 Open source
20202020-12-31	Operating cash flow	34881000	Operating Cash Flow: 34881000 Open source
20212021-12-31	Operating cash flow	-60382000	Operating Cash Flow: -60382000 Open source
20222022-12-31	Operating cash flow	-31631000	Operating Cash Flow: -31631000 Open source
20232023-12-31	Operating cash flow	-51161000	Operating Cash Flow: -51161000 Open source
20242024-12-31	Operating cash flow	-23674000	Operating Cash Flow: -23674000 Open source
20252025-12-31	Operating cash flow	-73941000	Operating Cash Flow: -73941000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -79.4M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-20343000	Operating Cash Flow: -19757000 Open source Capital Expenditure: 586000 Open source
20172017-12-31	Free cash flow	-52759000	Operating Cash Flow: -52026000 Open source Capital Expenditure: 733000 Open source
20182018-12-31	Free cash flow	-60045000	Operating Cash Flow: -59161000 Open source Capital Expenditure: 884000 Open source
20192019-12-31	Free cash flow	-51482000	Operating Cash Flow: -51435000 Open source Capital Expenditure: 47000 Open source
20202020-12-31	Free cash flow	34066000	Operating Cash Flow: 34881000 Open source Capital Expenditure: 815000 Open source
20212021-12-31	Free cash flow	-61467000	Operating Cash Flow: -60382000 Open source Capital Expenditure: 1085000 Open source
20222022-12-31	Free cash flow	-32832000	Operating Cash Flow: -31631000 Open source Capital Expenditure: 1201000 Open source
20232023-12-31	Free cash flow	-51367000	Operating Cash Flow: -51161000 Open source Capital Expenditure: 206000 Open source
20242024-12-31	Free cash flow	-32767000	Operating Cash Flow: -23674000 Open source Capital Expenditure: 9093000 Open source
20252025-12-31	Free cash flow	-79395000	Operating Cash Flow: -73941000 Open source Capital Expenditure: 5454000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

142.6% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	38.5%	Total Liabilities: 34344000 Open source Total Assets: 89301000 Open source
20172017-12-31	Liabilities / assets	48.7%	Total Liabilities: 49286000 Open source Total Assets: 101100000 Open source
20182018-12-31	Liabilities / assets	112.2%	Total Liabilities: 49900000 Open source Total Assets: 44482000 Open source
20192019-12-31	Liabilities / assets	91.6%	Total Liabilities: 91172000 Open source Total Assets: 99569000 Open source
20202020-12-31	Liabilities / assets	110.9%	Total Liabilities: 183441000 Open source Total Assets: 165435000 Open source
20212021-12-31	Liabilities / assets	85.9%	Total Liabilities: 137362000 Open source Total Assets: 159883000 Open source
20222022-12-31	Liabilities / assets	43.4%	Total Liabilities: 72058000 Open source Total Assets: 165886000 Open source
20232023-12-31	Liabilities / assets	145.8%	Total Liabilities: 444680000 Open source Total Assets: 305050000 Open source
20242024-12-31	Liabilities / assets	101.6%	Total Liabilities: 441825000 Open source Total Assets: 435023000 Open source
20252025-12-31	Liabilities / assets	142.6%	Total Liabilities: 422651000 Open source Total Assets: 296411000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

8.65× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	6.33×	Current Assets: 86816000 Open source Current Liabilities: 13706000 Open source
20172017-12-31	Current assets / current liabilities	8.99×	Current Assets: 98680000 Open source Current Liabilities: 10973000 Open source
20182018-12-31	Current assets / current liabilities	1.2×	Current Assets: 42076000 Open source Current Liabilities: 35144000 Open source
20192019-12-31	Current assets / current liabilities	2.77×	Current Assets: 96667000 Open source Current Liabilities: 34943000 Open source
20202020-12-31	Current assets / current liabilities	1.86×	Current Assets: 151343000 Open source Current Liabilities: 81547000 Open source
20212021-12-31	Current assets / current liabilities	2×	Current Assets: 144443000 Open source Current Liabilities: 72251000 Open source
20222022-12-31	Current assets / current liabilities	5.91×	Current Assets: 148138000 Open source Current Liabilities: 25077000 Open source
20232023-12-31	Current assets / current liabilities	1.33×	Current Assets: 90729000 Open source Current Liabilities: 68209000 Open source
20242024-12-31	Current assets / current liabilities	9.43×	Current Assets: 216626000 Open source Current Liabilities: 22976000 Open source
20252025-12-31	Current assets / current liabilities	8.65×	Current Assets: 129276000 Open source Current Liabilities: 14937000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 36.21 million Exact value Exact value: -36210000 USD 2016-01-01 – 2016-12-31: -36210000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SELECTA BIOSCIENCES, INC. · 2016-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Net Income: -36210000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36210000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368719000032/selectabiosciences10-k.htm#2399203 Filing: 000145368719000032 The citation records this snapshot. The page link may show a newer release later.	−USD 19.76 million Exact value Exact value: -19757000 USD 2016-01-01 – 2016-12-31: -19757000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SELECTA BIOSCIENCES, INC. · 2016-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Operating Cash Flow: -19757000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19757000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368719000032/selectabiosciences10-k.htm#2146747 Filing: 000145368719000032 The citation records this snapshot. The page link may show a newer release later.	USD 586,000 Exact value Exact value: 586000 USD 2016-01-01 – 2016-12-31: 586000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SELECTA BIOSCIENCES, INC. · 2016-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Capital Expenditure: 586000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 586000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368719000032/selectabiosciences10-k.htm#2156789 Filing: 000145368719000032 The citation records this snapshot. The page link may show a newer release later.	−USD 20.34 million Calculation and evidence -19757000 − 586000 USD Exact free cash flow: -20343000 USD 2016-01-01 – 2016-12-31: -19757000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 586000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SELECTA BIOSCIENCES, INC. · 2016-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Free cash flow: -20343000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19757000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368719000032/selectabiosciences10-k.htm#2146747 Filing: 000145368719000032 Input fundies:CapitalExpenditure: 586000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368719000032/selectabiosciences10-k.htm#2156789 Filing: 000145368719000032 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 65.32 million Exact value Exact value: -65321000 USD 2017-01-01 – 2017-12-31: -65321000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SELECTA BIOSCIENCES, INC. · 2017-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Net Income: -65321000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -65321000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368720000028/selectabiosciences10-k.htm#1792401 Filing: 000145368720000028 The citation records this snapshot. The page link may show a newer release later.	−USD 52.03 million Exact value Exact value: -52026000 USD 2017-01-01 – 2017-12-31: -52026000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SELECTA BIOSCIENCES, INC. · 2017-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Operating Cash Flow: -52026000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -52026000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368720000028/selectabiosciences10-k.htm#1836694 Filing: 000145368720000028 The citation records this snapshot. The page link may show a newer release later.	USD 733,000 Exact value Exact value: 733000 USD 2017-01-01 – 2017-12-31: 733000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SELECTA BIOSCIENCES, INC. · 2017-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Capital Expenditure: 733000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 733000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368720000028/selectabiosciences10-k.htm#1849409 Filing: 000145368720000028 The citation records this snapshot. The page link may show a newer release later.	−USD 52.76 million Calculation and evidence -52026000 − 733000 USD Exact free cash flow: -52759000 USD 2017-01-01 – 2017-12-31: -52026000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 733000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SELECTA BIOSCIENCES, INC. · 2017-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Free cash flow: -52759000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -52026000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368720000028/selectabiosciences10-k.htm#1836694 Filing: 000145368720000028 Input fundies:CapitalExpenditure: 733000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368720000028/selectabiosciences10-k.htm#1849409 Filing: 000145368720000028 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 65.34 million Exact value Exact value: -65336000 USD 2018-01-01 – 2018-12-31: -65336000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SELECTA BIOSCIENCES, INC. · 2018-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Net Income: -65336000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -65336000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368721000031/selb-20201231.htm#1410028 Filing: 000145368721000031 The citation records this snapshot. The page link may show a newer release later.	−USD 59.16 million Exact value Exact value: -59161000 USD 2018-01-01 – 2018-12-31: -59161000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SELECTA BIOSCIENCES, INC. · 2018-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Operating Cash Flow: -59161000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -59161000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368721000031/selb-20201231.htm#1461573 Filing: 000145368721000031 The citation records this snapshot. The page link may show a newer release later.	USD 884,000 Exact value Exact value: 884000 USD 2018-01-01 – 2018-12-31: 884000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SELECTA BIOSCIENCES, INC. · 2018-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Capital Expenditure: 884000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 884000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368721000031/selb-20201231.htm#1475884 Filing: 000145368721000031 The citation records this snapshot. The page link may show a newer release later.	−USD 60.05 million Calculation and evidence -59161000 − 884000 USD Exact free cash flow: -60045000 USD 2018-01-01 – 2018-12-31: -59161000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 884000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SELECTA BIOSCIENCES, INC. · 2018-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Free cash flow: -60045000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -59161000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368721000031/selb-20201231.htm#1461573 Filing: 000145368721000031 Input fundies:CapitalExpenditure: 884000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368721000031/selb-20201231.htm#1475884 Filing: 000145368721000031 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 55.35 million Exact value Exact value: -55350000 USD 2019-01-01 – 2019-12-31: -55350000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SELECTA BIOSCIENCES, INC. · 2019-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Net Income: -55350000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -55350000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368722000051/selb-20211231.htm#1734586 Filing: 000145368722000051 The citation records this snapshot. The page link may show a newer release later.	−USD 51.44 million Exact value Exact value: -51435000 USD 2019-01-01 – 2019-12-31: -51435000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SELECTA BIOSCIENCES, INC. · 2019-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Operating Cash Flow: -51435000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51435000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368722000051/selb-20211231.htm#1498308 Filing: 000145368722000051 The citation records this snapshot. The page link may show a newer release later.	USD 47,000 Exact value Exact value: 47000 USD 2019-01-01 – 2019-12-31: 47000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SELECTA BIOSCIENCES, INC. · 2019-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Capital Expenditure: 47000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 47000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368722000051/selb-20211231.htm#1516057 Filing: 000145368722000051 The citation records this snapshot. The page link may show a newer release later.	−USD 51.48 million Calculation and evidence -51435000 − 47000 USD Exact free cash flow: -51482000 USD 2019-01-01 – 2019-12-31: -51435000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 47000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SELECTA BIOSCIENCES, INC. · 2019-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Free cash flow: -51482000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51435000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368722000051/selb-20211231.htm#1498308 Filing: 000145368722000051 Input fundies:CapitalExpenditure: 47000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368722000051/selb-20211231.htm#1516057 Filing: 000145368722000051 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 68.88 million Exact value Exact value: -68876000 USD 2020-01-01 – 2020-12-31: -68876000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SELECTA BIOSCIENCES, INC. · 2020-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Net Income: -68876000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -68876000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000040/selb-20221231.htm#1767845 Filing: 000145368723000040 The citation records this snapshot. The page link may show a newer release later.	USD 34.88 million Exact value Exact value: 34881000 USD 2020-01-01 – 2020-12-31: 34881000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SELECTA BIOSCIENCES, INC. · 2020-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Operating Cash Flow: 34881000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 34881000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000040/selb-20221231.htm#1523945 Filing: 000145368723000040 The citation records this snapshot. The page link may show a newer release later.	USD 815,000 Exact value Exact value: 815000 USD 2020-01-01 – 2020-12-31: 815000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SELECTA BIOSCIENCES, INC. · 2020-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Capital Expenditure: 815000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 815000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000040/selb-20221231.htm#1538807 Filing: 000145368723000040 The citation records this snapshot. The page link may show a newer release later.	USD 34.07 million Calculation and evidence 34881000 − 815000 USD Exact free cash flow: 34066000 USD 2020-01-01 – 2020-12-31: 34881000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 815000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SELECTA BIOSCIENCES, INC. · 2020-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Free cash flow: 34066000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 34881000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000040/selb-20221231.htm#1523945 Filing: 000145368723000040 Input fundies:CapitalExpenditure: 815000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000040/selb-20221231.htm#1538807 Filing: 000145368723000040 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 25.69 million Exact value Exact value: -25687000 USD 2021-01-01 – 2021-12-31: -25687000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SELECTA BIOSCIENCES, INC. · 2021-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Net Income: -25687000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25687000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm#1681677 Filing: 000145368724000036 The citation records this snapshot. The page link may show a newer release later.	−USD 60.38 million Exact value Exact value: -60382000 USD 2021-01-01 – 2021-12-31: -60382000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SELECTA BIOSCIENCES, INC. · 2021-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Operating Cash Flow: -60382000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -60382000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm#1433268 Filing: 000145368724000036 The citation records this snapshot. The page link may show a newer release later.	USD 1.09 million Exact value Exact value: 1085000 USD 2021-01-01 – 2021-12-31: 1085000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SELECTA BIOSCIENCES, INC. · 2021-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Capital Expenditure: 1085000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1085000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm#1445370 Filing: 000145368724000036 The citation records this snapshot. The page link may show a newer release later.	−USD 61.47 million Calculation and evidence -60382000 − 1085000 USD Exact free cash flow: -61467000 USD 2021-01-01 – 2021-12-31: -60382000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1085000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SELECTA BIOSCIENCES, INC. · 2021-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Free cash flow: -61467000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -60382000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm#1433268 Filing: 000145368724000036 Input fundies:CapitalExpenditure: 1085000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm#1445370 Filing: 000145368724000036 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 35.38 million Exact value Exact value: 35379000 USD 2022-01-01 – 2022-12-31: 35379000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SELECTA BIOSCIENCES, INC. · 2022-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Net Income: 35379000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 35379000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm#1680909 Filing: 000145368724000036 The citation records this snapshot. The page link may show a newer release later.	−USD 31.63 million Exact value Exact value: -31631000 USD 2022-01-01 – 2022-12-31: -31631000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SELECTA BIOSCIENCES, INC. · 2022-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Operating Cash Flow: -31631000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31631000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm#1432606 Filing: 000145368724000036 The citation records this snapshot. The page link may show a newer release later.	USD 1.2 million Exact value Exact value: 1201000 USD 2022-01-01 – 2022-12-31: 1201000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SELECTA BIOSCIENCES, INC. · 2022-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Capital Expenditure: 1201000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1201000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm#1444776 Filing: 000145368724000036 The citation records this snapshot. The page link may show a newer release later.	−USD 32.83 million Calculation and evidence -31631000 − 1201000 USD Exact free cash flow: -32832000 USD 2022-01-01 – 2022-12-31: -31631000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1201000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SELECTA BIOSCIENCES, INC. · 2022-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Free cash flow: -32832000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31631000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm#1432606 Filing: 000145368724000036 Input fundies:CapitalExpenditure: 1201000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368724000036/rnac-20231231.htm#1444776 Filing: 000145368724000036 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 219.71 million Exact value Exact value: -219710000 USD 2023-01-01 – 2023-12-31: -219710000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SELECTA BIOSCIENCES, INC. · 2023-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Net Income: -219710000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -219710000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000060/rnac-20241231.htm#1702147 Filing: 000145368725000060 The citation records this snapshot. The page link may show a newer release later.	−USD 51.16 million Exact value Exact value: -51161000 USD 2023-01-01 – 2023-12-31: -51161000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SELECTA BIOSCIENCES, INC. · 2023-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Operating Cash Flow: -51161000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51161000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000060/rnac-20241231.htm#1504745 Filing: 000145368725000060 The citation records this snapshot. The page link may show a newer release later.	USD 206,000 Exact value Exact value: 206000 USD 2023-01-01 – 2023-12-31: 206000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SELECTA BIOSCIENCES, INC. · 2023-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Capital Expenditure: 206000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 206000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000060/rnac-20241231.htm#1511727 Filing: 000145368725000060 The citation records this snapshot. The page link may show a newer release later.	−USD 51.37 million Calculation and evidence -51161000 − 206000 USD Exact free cash flow: -51367000 USD 2023-01-01 – 2023-12-31: -51161000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 206000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SELECTA BIOSCIENCES, INC. · 2023-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Free cash flow: -51367000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51161000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000060/rnac-20241231.htm#1504745 Filing: 000145368725000060 Input fundies:CapitalExpenditure: 206000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000060/rnac-20241231.htm#1511727 Filing: 000145368725000060 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 77.42 million Exact value Exact value: -77424000 USD 2024-01-01 – 2024-12-31: -77424000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SELECTA BIOSCIENCES, INC. · 2024-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Net Income: -77424000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -77424000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1347529 Filing: 000145368726000064 The citation records this snapshot. The page link may show a newer release later.	−USD 23.67 million Exact value Exact value: -23674000 USD 2024-01-01 – 2024-12-31: -23674000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SELECTA BIOSCIENCES, INC. · 2024-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Operating Cash Flow: -23674000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23674000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1377801 Filing: 000145368726000064 The citation records this snapshot. The page link may show a newer release later.	USD 9.09 million Exact value Exact value: 9093000 USD 2024-01-01 – 2024-12-31: 9093000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SELECTA BIOSCIENCES, INC. · 2024-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Capital Expenditure: 9093000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9093000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1382223 Filing: 000145368726000064 The citation records this snapshot. The page link may show a newer release later.	−USD 32.77 million Calculation and evidence -23674000 − 9093000 USD Exact free cash flow: -32767000 USD 2024-01-01 – 2024-12-31: -23674000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 9093000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SELECTA BIOSCIENCES, INC. · 2024-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Free cash flow: -32767000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23674000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1377801 Filing: 000145368726000064 Input fundies:CapitalExpenditure: 9093000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1382223 Filing: 000145368726000064 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 130.3 million Exact value Exact value: -130302000 USD 2025-01-01 – 2025-12-31: -130302000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SELECTA BIOSCIENCES, INC. · 2025-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Net Income: -130302000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -130302000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1346755 Filing: 000145368726000064 The citation records this snapshot. The page link may show a newer release later.	−USD 73.94 million Exact value Exact value: -73941000 USD 2025-01-01 – 2025-12-31: -73941000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SELECTA BIOSCIENCES, INC. · 2025-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Operating Cash Flow: -73941000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -73941000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1377143 Filing: 000145368726000064 The citation records this snapshot. The page link may show a newer release later.	USD 5.45 million Exact value Exact value: 5454000 USD 2025-01-01 – 2025-12-31: 5454000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SELECTA BIOSCIENCES, INC. · 2025-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Capital Expenditure: 5454000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5454000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1381633 Filing: 000145368726000064 The citation records this snapshot. The page link may show a newer release later.	−USD 79.4 million Calculation and evidence -73941000 − 5454000 USD Exact free cash flow: -79395000 USD 2025-01-01 – 2025-12-31: -73941000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 5454000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SELECTA BIOSCIENCES, INC. · 2025-12-31 SELECTA BIOSCIENCES, INC. (edgar:1453687) Free cash flow: -79395000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:41:53Z Snapshot: 01759a032b36429fa2cc6cd58ee73bc988942c73478691c2d3420eb269988beb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1453687?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -73941000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1377143 Filing: 000145368726000064 Input fundies:CapitalExpenditure: 5454000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000064/rnac-20251231.htm#1381633 Filing: 000145368726000064 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

83 filings · 3,377 latest values · 3,342 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001453687, 1453687, RNAC, SELB, edgar:1453687

Also known as CARTESIAN THERAPEUTICS, INC., Cartesian Therapeutics, Inc., SELECTA BIOSCIENCES INC, SELECTA BIOSCIENCES, INC., Selecta Biosciences, Inc, Selecta Biosciences, Inc.

SELECTA BIOSCIENCES, INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation